Histamine plays a central role in the secretion of gastric acid in the stomach. Histamine is produced by enterochromaffin-like cells and mast cells in the stomach in response to food entering the stomach. When histamine is released, it binds to H2 receptors on parietal cells in the stomach lining. This triggers a signaling cascade that results in the parietal cells secreting hydrochloric acid to aid in digestion. 

The structure of histamine is fairly simple, composed of an imidazole ring attached to an ethylamine chain. However, this structure allows histamine to act as a potent signaler in the body. By understanding the structure of histamine and how it interacts with H2 receptors, scientists were able to develop H2 receptor antagonist drugs, commonly known as H2 blockers, to reduce stomach acid secretion. These drugs, such as ranitidine, famotidine, and cimetidine, work by blocking the binding of histamine to H2 receptors. This inhibits the signaling pathway that leads to hydrochloric acid secretion by parietal cells.

H2 blockers have been instrumental in the treatment and healing of peptic ulcer disease. Peptic ulcers are sores in the lining of the stomach or upper intestine, and they are often caused or exacerbated by excess stomach acid. By reducing acid levels in the stomach, H2 blockers allow peptic ulcers to heal and provide relief from symptoms like indigestion, burning stomach pain, nausea, and vomiting. Although proton pump inhibitors have largely replaced H2 blockers for peptic ulcer treatment due to greater acid suppression, H2 blockers are still used for some patients.

In summary, histamine and its interaction with H2 receptors in the stomach drives the secretion of hydrochloric acid, which aids digestion but can also contribute to peptic ulcer disease at high levels. The simple structure of histamine enabled scientists to develop H2 receptor antagonist drugs that block this interaction and reduce stomach acid. These H2 blockers have played an important role in allowing peptic ulcers to heal by correcting the acid imbalance that contributes to them. Understanding biological signaling pathways and structures at a molecular level has enabled these types of targeted drug interventions that have benefited human health.